Mutual Loses Bid For Injunction In Colchicine Suit
A federal judge has rejected Mutual Pharmaceutical Co. Inc.'s request for a preliminary injunction barring Watson Pharmaceuticals Inc. from claiming that its version of gout treatment colchicine is approved by the...To view the full article, register now.
Already a subscriber? Click here to view full article